Lee A. Witters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lee A. Witters has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Bruce E. Kemp
St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne & Mary MacKillop Institute for Health Research, Australian Catholic University Fitzroy, Fitzroy, Victoria, Australia
3 shared publications Anthony R. Means
2 shared publicationsChristine Richardson
2 shared publicationsDavid Stapleton
St. Vincent's Institute of Medical Research, St. Vincent's Hospital, 41 Victoria Parade, Fitzroy, Vic. 3065, Australia
2 shared publicationsAndrew Hammet
St. Vincent's Institute of Medical Research, St. Vincent's Hospital, 41 Victoria Parade, Fitzroy, Vic. 3065, Australia
1 shared publicationAnthony R Means
Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA
1 shared publication
Latest Publications
- Open Access
- 1 March 2007
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 292 (3) , E802-E811
Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation
The AMP-activated protein kinase (AMPK) is an important metabolic sensor/effector that coordinates many of the changes in mammalian tissues during variations in energy availability. We have sought to create an in vivo genetic model of chronic AMPK activation, selecting murine skeletal muscle as a representative tissue where AMPK plays important roles. Muscle-selective expression of a mutant noncatalytic γ1 subunit (R70Qγ) of AMPK activates AMPK and increases muscle glycogen content. The increase in glycogen content requires the presence of the endogenous AMPK catalytic α-subunit, since the offspring of cross-breeding of these mice with mice expressing a dominant negative AMPKα subunit have normal glycogen content. In R70Qγ1-expressing mice, there is a small, but significant, increase in muscle glycogen synthase (GSY) activity associated with an increase in the muscle expression of the liver isoform GSY2. The increase in glycogen content is accompanied, as might be expected, by an increase in exercise capacity. Transgene expression of this mutant AMPKγ1 subunit may provide a useful model for the chronic activation of AMPK in other tissues to clarify its multiple roles in the regulation of metabolism and other physiological processes.
- 1 March 2007
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 292 (3) , E802-E811
Open AccessGenetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation
The AMP-activated protein kinase (AMPK) is an important metabolic sensor/effector that coordinates many of the changes in mammalian tissues during variations in energy availability. We have sought to create an in vivo genetic model of chronic AMPK activation, selecting murine skeletal muscle as a representative tissue where AMPK plays important roles. Muscle-selective expression of a mutant noncatalytic γ1 subunit (R70Qγ) of AMPK activates AMPK and increases muscle glycogen content. The increase in glycogen content requires the presence of the endogenous AMPK catalytic α-subunit, since the offspring of cross-breeding of these mice with mice expressing a dominant negative AMPKα subunit have normal glycogen content. In R70Qγ1-expressing mice, there is a small, but significant, increase in muscle glycogen synthase (GSY) activity associated with an increase in the muscle expression of the liver isoform GSY2. The increase in glycogen content is accompanied, as might be expected, by an increase in exercise capacity. Transgene expression of this mutant AMPKγ1 subunit may provide a useful model for the chronic activation of AMPK in other tissues to clarify its multiple roles in the regulation of metabolism and other physiological processes.
- 1 January 2006
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 31 (1) , 13-16
Chutes and Ladders: the search for protein kinases that act on AMPK
- 1 January 2006
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 31 (1) , 13-16
Chutes and Ladders: the search for protein kinases that act on AMPK
- Top Cited PapersOpen Access
- 1 August 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (32) , 29060-29066
The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases
- 1 August 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (32) , 29060-29066
Top Cited PapersOpen AccessThe Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases
- 10 May 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (3) , 892-898
AMP-activated protein kinase kinase: detection with recombinant AMPK α1 subunit
- 10 May 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (3) , 892-898
AMP-activated protein kinase kinase: detection with recombinant AMPK α1 subunit
- Open Access
- 15 October 2001
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 108 (8) , 1105-1107
The blooming of the French lilac
- 15 October 2001
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 108 (8) , 1105-1107
Open AccessThe blooming of the French lilac
- 1 March 2001
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 354 (2) , 275-283
Post-translational modifications of the β-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization
The AMP-activated protein kinase (AMPK) is a ubiquitous mammalian protein kinase important in the adaptation of cells to metabolic stress. The enzyme is a heterotrimer, consisting of a catalytic α subunit and regulatory β and γ subunits, each of which is a member of a larger isoform family. The enzyme is allosterically regulated by AMP and by phosphorylation of the α subunit. The β subunit is post-translationally modified by myristoylation and multi-site phosphorylation. In the present study, we have examined the impact of post-translational modification of the β-1 subunit on enzyme activity, heterotrimer assembly and subcellular localization, using site-directed mutagenesis and expression of subunits in mammalian cells. Removal of the myristoylation site (G2A mutant) results in a 4-fold activation of the enzyme and relocalization of the β subunit from a particulate extranuclear distribution to a more homogenous cell distribution. Mutation of the serine-108 phosphorylation site to alanine is associated with enzyme inhibition, but no change in cell localization. In contrast, the phosphorylation site mutations, SS24,25AA and S182A, while having no effects on enzyme activity, are associated with nuclear redistribution of the subunit. Taken together, these results indicate that both myristoylation and phosphorylation of the β subunit of AMPK modulate enzyme activity and subunit cellular localization, increasing the complexity of AMPK regulation.
- 1 March 2001
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 354 (2) , 275-283
Post-translational modifications of the β-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization
The AMP-activated protein kinase (AMPK) is a ubiquitous mammalian protein kinase important in the adaptation of cells to metabolic stress. The enzyme is a heterotrimer, consisting of a catalytic α subunit and regulatory β and γ subunits, each of which is a member of a larger isoform family. The enzyme is allosterically regulated by AMP and by phosphorylation of the α subunit. The β subunit is post-translationally modified by myristoylation and multi-site phosphorylation. In the present study, we have examined the impact of post-translational modification of the β-1 subunit on enzyme activity, heterotrimer assembly and subcellular localization, using site-directed mutagenesis and expression of subunits in mammalian cells. Removal of the myristoylation site (G2A mutant) results in a 4-fold activation of the enzyme and relocalization of the β subunit from a particulate extranuclear distribution to a more homogenous cell distribution. Mutation of the serine-108 phosphorylation site to alanine is associated with enzyme inhibition, but no change in cell localization. In contrast, the phosphorylation site mutations, SS24,25AA and S182A, while having no effects on enzyme activity, are associated with nuclear redistribution of the subunit. Taken together, these results indicate that both myristoylation and phosphorylation of the β subunit of AMPK modulate enzyme activity and subunit cellular localization, increasing the complexity of AMPK regulation.